FRONTIER BIOTECHNOLOGIES Inc.

News

FRONTIER BIOTECHNOLOGIES Inc
Home>News>Frontier Biotech Announces the Appointment of Dr. Jing Bao to its Senior Management Team

Frontier Biotech Announces the Appointment of Dr. Jing Bao to its Senior Management Team

  • 2010-04-07  10:59:39


2018-04-02 16:37:25

Dr. Jing Bao was appointed to Vice President Clinical Development at Frontier Biotech. Dr. Bao has 16 years’ experience in global clinical trials oversight, scientific administration, pharmacovigilance, technology transfer, and 10 years’ experience as a practicing physician.  Prior to joining Frontier Biotech, she was a Medical Officer at the Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health (NIH). She pioneered NIH-China clinical research collaboration and served as the China Liaison for Alliance for Clinical Research Excellence and Safety. She is also the Chair of Washington DC Chapter of American Women for International Understanding and a member of Asian American Government Executives Network. Dr. Bao holds a PhD from the Weizmann Institute of Science in Israel and a MD from Southeast University Medical School in China. 
Dr. CJ Wang, CEO of Frontier Biotech, said “We are excited to welcome Dr. Jing Bao, an experienced clinician, to Frontier Biotech. The timing is perfect as we are about to start a phase 2 clinical trial of our all-injectable long-acting novel drug combination “Albuvirtide + 3BNC117” in the US and China. I believe her expertise in AIDS and infectious diseases, and a wealth of global clinical development experience will help Frontier Biotech become an internationally competitive biopharma company.”


Innovative solutions to promote human health